Kayla Rivas

Merck to request emergency approval for COVID-19 antiviral pill

Merck will request emergency approval for an experimental oral COVID-19 antiviral drug, molnupiravir, after a late-stage trial indicated an approximate 50% risk reduction for hospitalization or death among patients with mild to moderate COVID-19.

Pfizer-BioNTech submit COVID-19 vaccine data to FDA for kids 5-11

Pfizer-BioNTech submitted clinical trial data from a COVID-19 vaccine study among kids ages 5-11 to the Food and Drug Administration (FDA), the companies announced Tuesday. A request for emergency approval is anticipated to follow in the coming weeks.

J&J's new CEO Joaquin Duato: What to know

Johnson & Johnson announced longstanding CEO Alex Gorsky will transition out of the role, with Joaquin Duato set to lead the health care company effective Jan. 3.